Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Sunshine Biopharma
Recent news which mentions Sunshine Biopharma
Insider Buying: Sunshine Biopharma Inc. (NASDAQ: SBFM) Chief Financial Officer Purchases Shares
December 12, 2022
Tickers
SBFM
Tags
Insider Buying
Penny Stocks
Benzinga
From
Benzinga
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
December 08, 2022
Tickers
AAPL
LLY
PFE
REGN
Tags
Benzinga
Biotech
REGN
From
Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
November 07, 2022
Tickers
SBFM
SLGL
VTRS
Tags
Biotech
Benzinga
Penny Stocks
From
Benzinga
Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
August 30, 2022
Tickers
HLF
MSLP
SBFM
Tags
SBFM
General
Partner Content
From
Benzinga
Pharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall
August 11, 2022
Tickers
BNTX
MRNA
PFE
SBFM
Tags
PFE
Biotech
Penny Stocks
From
Benzinga
Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
August 08, 2022
Tickers
SBFM
SBFMW
Tags
News
Benzinga
Penny Stocks
From
Benzinga
SUNSHINE BIOPHARMA INCREASES SUPPORT FOR ANTI-CORONAVIRUS COLLABORATIVE RESEARCH WITH THE UNIVERSITY OF ARIZONA
July 28, 2022
Tags
Press Releases
Sunshine Biopharma
Market News
From
Benzinga
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
Partner Content
Sunshine Biopharma
General
From
Benzinga
Sunshine Biopharma Prepares For IND Study Of Novel Cancer Drug That It Expects Could Beat Multidrug-Resistant Cancer
May 26, 2022
Tickers
BMY
PFE
SBFM
Tags
Market News
Sunshine Biopharma
Partner Content
From
Benzinga
Sunshine Biopharma Boasts Of Management Team With Wealth Of Medical And Scientific Knowledge
May 03, 2022
Tickers
SBFM
Tags
Biotech
Penny Stocks
Benzinga
From
Benzinga
Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
April 26, 2022
Tickers
SBFM
SBFMW
Tags
Sunshine Biopharma
Market News
Partner Content
From
Benzinga
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
April 25, 2022
Tickers
SBFM
SBFMW
Tags
Market News
Sunshine Biopharma
Partner Content
From
Benzinga
EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments
April 19, 2022
Tickers
SBFM
Tags
Benzinga
Interview
Biotech
From
Benzinga
Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells
April 06, 2022
Tickers
SBFM
SBFMW
Tags
Sunshine Biopharma
Market News
Partner Content
From
Benzinga
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
March 24, 2022
Tickers
BMY
PFE
SB
SBFM
Tags
BMY
SB
SBFM
From
Benzinga
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market
March 14, 2022
Tickers
SBFM
SBFMW
Tags
Partner Content
Sunshine Biopharma
Market News
From
Benzinga
Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
February 17, 2022
Tags
General
Partner Content
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.